Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2015
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Bayer
- 07 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Jan 2013 Planned End Date changed from 1 Dec 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.